glp-1 agonists muscle loss Hidden Risks of Inhibitors: and "Ozempic Face" Comment “Curious” for the deep

Its also linked to metabolic disorders such as diabetes, and has been associated with depression and potentially cancer. Could help lower risk of some cancers A recent study looked at medical records for more than 10,000 people with early-stage cancer and found that those who took GLP-1s had a significantly lower risk of their cancer spreading than those who did not

Glucagon-like peptide-1 receptor agonists and cardiovascular events: class effects versus individual patterns

The first reported GLP-1/GIP co-agonists, which had prolonged half-lives due to the use of fatty acylation or PEGylation, yielded synergistic effects, lowering body weight in obese rodents relative to the individual mono-agonist comparators [465] and having a greater insulinotropic effect in non-human primates

Wilmington, DE

American Journal of Physiology Renal Physiology

12, pp